Stock UniverseDerived research view · source repositories remain read-only

Prestige Consumer Healthcare Inc. (PBH)

Therapeutics / Biopharma · Healthcare / Drug Manufacturers - Specialty & Generic
Score Band
Watch
Selection Score
32.87
Global Rank
1566
Market Cap
3.28B
Latest Close
47.18
RS Composite
-29.10% · G#3000

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-13.13%
3M
-29.78%
6M
-21.73%
1Y
-44.36%
3Y
-17.56%
5Y
-5.39%
10Y
-12.69%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 404.60K · 30-day average: 759.64K · Max drawdown over stored range: -53.75%

Research Snapshot

Relative Strength vs SPX

RS Composite-29.10%
20D RS-14.21%
60D RS-36.17%
120D RS-29.47%
Global RS Rank3000 · 10.58% percentile
Watch+Speculative RS Rank1847 · 11.92% percentile
Group ScopeWatch+Speculative
Primary RS Rank364 · 20.52% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank197 / 701
Primary Percentile72.04
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2025-12-312026-02-051.10B619.29M322.35M186.50M3.78492.15M13.22M478.92M49M56.12%29.21%16.90%44.59%43.40%62.37M1.03B

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2025-12-31$3.7812.5x$22.382.1x$9.714.9x$9.984.7x

Shares Diluted: 49M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Revenue943.3651086.8121127.7251125.3571137.7621088.71
Revenue Growth (YoY)-2.04%15.206%3.764%-0.21%1.102%-4.311%
Gross Profit553.695627.87632.842632.571643.346
Operating Income299.836336.076347.802342.429349.241
Free Cash Flow213.364250.28221.932239.376243.291246.449
Free Cash Flow Per Share4.2164.9234.4494.7714.8585.05848
EPS (Diluted) GAAP3.254.04-1.654.174.29
EPS Growth16.906%24.308%9600%9600%2.878%-8.858%
EPS Non-GAAP
Gross Margin58.694%57.772%56.117%56.211%56.545%54.7052%
Operating Margin31.784%30.923%30.841%30.428%30.695%28.4199%
Profit Margin17.457%18.898%-7.298%18.602%18.862%17.4796%
Free Cash Flow Margin22.617%23.029%19.68%21.271%21.383%22.6369%
Shares Outstanding (Diluted)50.60550.84249.88950.17850.0848.72
Shares Change (YoY)-1.046%0.468%-1.874%0.579%-0.195%-2.716%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q32026-02-05283.44M55.52%82.49M29.10%46.70M16.47%0.9748.09M62.37M1.03Bprocessed
2026 Q22025-11-06274.11M55.30%79.67M29.06%42.21M15.40%0.8649.26M119.11M993.15Mprocessed
2026 Q12025-08-07249.53M56.24%71.76M28.76%47.47M19.02%0.9549.83M139.50M992.75Mprocessed
2025 Q42025-05-09296.52M57.34%88.43M29.82%50.13M16.91%1.0050.06M97.88M992.36Mprocessed
2025 Q32025-02-06290.32M55.47%91.96M31.68%61.03M21.02%1.2249.99M50.87M1.00Bprocessed
2025 Q22024-11-07283.79M55.46%84.34M29.72%54.38M19.16%1.0950.00M51.54M1.06Bprocessed
2025 Q12024-08-08267.14M54.66%72.05M26.97%49.07M18.37%0.9850.27M34.26M1.10Bprocessed
2024 Q42024-05-15276.99M54.81%82.15M29.66%49.46M17.86%0.9850.31M46.47M1.13Bprocessed
2024 Q32024-02-08282.74M55.86%86.83M30.71%53.05M18.76%1.0650.12M63.62M1.21Bprocessed
2024 Q22023-11-02286.32M55.89%88.25M30.82%53.56M18.71%1.0750.08M60.07M1.27Bprocessed
2024 Q12023-08-03279.31M55.38%85.19M30.50%53.28M19.07%1.0650.20M54.58M1.33Bprocessed
2023 Q42023-05-05285.87M53.79%-281.00M-98.30%-240.55M-84.15%-4.9748.38M58.49M1.35Bprocessed
2023 Q32023-02-02275.52M54.59%87.18M31.64%51.95M18.86%1.0450.19M86.36M1.44Bprocessed
2023 Q22022-11-03289.27M55.66%84.38M29.17%51.02M17.64%1.0250.27M42.44M1.46Bprocessed
2023 Q12022-08-04277.06M57.79%87.01M31.41%55.27M19.95%1.0950.73M35.87M1.49Bprocessed
2022 Q42022-05-06266.94M55.77%77.42M29.01%52.09M19.51%1.0250.97M27.18M1.48Bprocessed
2022 Q32022-02-03274.47M56.49%82.59M30.09%50.22M18.30%0.9950.94M21.02M1.55Bprocessed
2022 Q22021-11-04276.23M57.10%78.56M28.44%45.33M16.41%0.8950.79M42.82M1.61Bprocessed
2022 Q12021-08-05269.18M59.07%91.34M33.93%57.76M21.46%1.1450.67M163.62M1.55Bprocessed
2021 Q42021-05-07237.76M57.64%70.94M29.84%35.51M14.94%0.7050.52M32.30M1.48Bprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.